SB203580, the p38 mitogen-activated protein kinase inhibitor blocks the inhibitory effect of β-amyloid on long-term potentiation in the rat hippocampus

Neuroscience Letters

Volumn 288, Issue 2, 2000, Pages 119-122

  Saleshando, Gagoitsewe ^a   O'Connor, John J ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Hippocampus; Long term potentiation; p38 Mitogen activated protein kinase; SB203580; Amyloid

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; AMYLOID BETA PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PICROTOXIN; SYNAPTOPHYSIN;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DENTATE GYRUS; ELECTROSTIMULATION; HIPPOCAMPUS; LONG TERM POTENTIATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION;

AMYLOID BETA-PROTEIN; ANIMALS; ENZYME INHIBITORS; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; IMIDAZOLES; LONG-TERM POTENTIATION; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDE FRAGMENTS; PYRIDINES; RATS; RATS, WISTAR; SYNAPTIC TRANSMISSION;

EID: 0034648038     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01210-6     Document Type: Article

References (26)

1. Bellinger F.P., Madamba S., Siggins G.R. Interleukin-1β inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res. 628:1993;227-234.
2. Bliss T.V.P., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 361:1993;31-38.
3. Boland K., Behrens M., Choi D., Manias K., Perlmutter D.H. The serpine-enzyme complex receptor recognizes soluble, nontoxic amyloid-beta peptide but not aggregated, cytotoxic amyloid-beta peptide. J. Biol. Chem. 271:1996;18032-18044.
4. Chen Q.S., Kagan B.L., Hirakura Y., Xie C.W. Impairment of long-term potentiation by alzheimer amyloid beta-peptides. J. Neurosci. Res. 60:2000;65-72.
5. Coogan A., O'Neill L.A.J., O'Connor J.J. The p38 MAP kinase inhibitor SB203580 antagonizes the inhibitory effect of interleukin-1β on long-term potentiation in the rat dentate gyrus in vitro. Neuroscience. 93:1999;57-69.
6. Cullen W.K., Suh Y.H., Anwyl R., Rowan M.J. Block of LTP in rat hippocampus in vivo by β-amyloid precursor protein fragments. NeuroReport. 8:1997;3213-3217.
7. Cullen W.K., Wu J., Anwyl R., Rowan M.J. β-amyloid produces a delayed NMDA receptor-dependent reduction in synaptic transmission in rat hippocampus. NeuroReport. 8:1997;87-92.
8. Cunningham A.J., Murray C.A., O'Neill L.A.J., Lynch M.A., O'Connor J.J. Interleukin-1β (IL-1β) and tumour necrosis factor (TNF) inhibit long-term potentiaton in the rat dentate gyrus in vitro. Neurosci. Lett. 203:1996;1-4.
9. Ekinci F.J., Malik K.U., Shea T.B. Activation of the L-voltage-sensitive calcium channel by mitogen-activated protein (MAP) kinase following exposure of neuronal cells to β-amyloid. J. Biol. Chem. 274:1999;30322-30327.
10. El Khoury J., Hickman S.E., Thomas C.A. Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature. 382:1996;716-719.
11. Griffin W.S., Stanley L.C., Ling C., White L., McLeod V., Perrot L.J., White C.L. Brain interleukin-1 and S-100 immunoreactivity are elevated in Down's syndrome and Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 86:1989;7611-7615.
12. Gunn-Moore F.J., Tavare J.M. Apoptosis of cerebellar granule cells induced by serum withdrawal, glutamate or β-amyloid, is independent of Jun kinase or p38 mitogen activated protein kinase activation. Neurosci. Lett. 250:1998;53-56.
13. Ishida A., Furukawa K., Keller J.N., Mattson M.P. Secreted forms of β-amyloid precursor protein shifts the frequency dependency for the induction of LTD, and enhances LTP in hippocampal slices. NeuroReport. 8:1997;2133-3137.
14. McDonald D.R., Bamberger M.A., Combs C.K., Landreth G.E. β-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes. J. Neurosci. 18:1998;4451-4460.
15. Mills J., Reiner P.B. Mitogen-activated protein kinase is involved in N-methyl D-asparate receptor regulation of amyloid precursor protein cleavage. Neuroscience. 94:1999;1333-1338.
16. O'Leary D.M., Cassidy E.M., O'Connor J.J. Type II and III metabotropic glutamate receptors modulate paired pulse depression in the rat dentate gyrus in vitro. Eur. J. Pharmacol. 340:1997;35-44.
17. Pike C.J., Walencewicz-Wasserman A.J., Kosmoski J., Cribbs D.H., Glabe C.G., Cotman C.W. Structure-activity analyses of β-amyloid peptides: contribution of the β25-35 region to aggregation and neurotoxicity. J. Neurochem. 64:1995;253-265.
18. 2+ current in rat cerebellar granule neurones. NeuroReport. 9:1998;539-545.
19. Pyo H., Jou I., Jung S., Joe E.H. Mitogen-activated protein kinases activated by lipopolysaccharide and beta-amyloid in cultured rat microglia. NeuroReport. 9:1998;871-874.
20. Samuel W., Masliah E., Hill L.R., Butters N., Terry R. Hippocampal connectivity and Alzheimer's dementia: effects of synapse loss and tangle frequency in a two-component model. Neurology. 44:1994;2081-2088.
21. Selkoe D.J. Amyloid β-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271:1996;18295-18298.
22. 2+ influx through L-type voltage sensitive channels: a possible involvement of free radicals. J. Neurochem. 68:1997;265-271.
23. Wadsworth S.A., Cavender D.E., Beers S.A., Lalan P., Schafer P.H., Malloy E.A., Wu W., Fahmy B., Olini G.C., Davies J.E., Pellegrino-Gensey J.L., Wachter M.P., Siekierka J.J. RWJ 67657, a potent, orally active inhibitor of p38 mitogen-activated protein kinase. J. Pharmacol. Exp. Ther. 291:1999;680-687.
24. Wu J., Anwyl R., Rowan M.J. β-amyloid-(1-40) increases long-term potentiation in rat hippocampus in vitro. Eur. J. Pharmacol. 284:1995;121-123.
25. Wu J., Anwyl R., Rowan M.J. β-amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus. NeuroReport. 6:1995;2409-2413.
26. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A.M. RAGE and amyloid beta peptide neurotoxicity in Alzheimer's disease. Nature. 382:1996;685-691.